Company Filing History:
28 out of 3,539 
5 out of 41 
Years Active: 2017-2025
Title: Celebrating the Innovations of James Noble Kochenderfer
Introduction: James Noble Kochenderfer, an esteemed inventor based in Bethesda, MD, has made significant contributions to the field of biomedical research, particularly in the development of innovative therapies for cancer treatment. With a remarkable portfolio of 25 patents, Kochenderfer has positioned himself as a leading inventor focused on enhancing patient outcomes through cutting-edge technologies.
Latest Patents: Among his latest inventions are two groundbreaking patents. The first, titled "Chimeric antigen receptors targeting B-cell maturation antigen," introduces an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) aimed at combating multiple myeloma cells. This invention also details the utilization of host cells, such as T-cells or natural killer (NK) cells, that express the CAR, providing a novel approach to cancer therapy. The second patent, "Diagnostic methods for T cell therapy," outlines methods designed to increase the efficacy of T cell therapies. This includes identifying patients who would benefit the most from T cell therapy, employing preconditioning agents, and identifying biomarker cytokines prior to treatment.
Career Highlights: James Kochenderfer's career spans significant organizations, including the United States Department of Health and Human Services and Kite Pharma, Inc. His work at these institutions has been instrumental in advancing therapeutic techniques and ensuring better treatment strategies for patients battling various forms of cancer.
Collaborations: Kochenderfer has had the privilege of collaborating with notable professionals, including Adrian I Bot and Jeffrey S Wiezorek. Their combined expertise has contributed to the success of his innovative projects, strengthening the foundations of the therapies being developed.
Conclusion: James Noble Kochenderfer’s dedication to innovation in the medical field has resulted in numerous patents that hold the promise of transforming patient care, particularly in oncology. His innovative spirit and collaborations with fellow experts underscore the importance of teamwork and creativity in advancing biomedical research and therapeutic interventions.